Literature DB >> 29602132

Increased expression of circRNA_102231 in lung cancer and its clinical significance.

Liang Zong1, Qingchao Sun1, Haiping Zhang1, Zhixiang Chen1, Yanchao Deng1, Desheng Li1, Liwei Zhang2.   

Abstract

Circular RNAs (circRNAs) are a type of endogenous non-coding RNAs which implicated in the progression of cancers. However, the role of circRNA_102231 in lung cancer remains unclear. Gene Expression Omnibus (GEO) datasets were used to investigate aberrantly expressed circRNAs in lung cancer. CircRNA_102231 expression in lung adenocarcinoma (LAC) tissues was dertermined by qRT-PCR. Furthermore, we explored the functions of circRNA_102231 on lung cancer cells progression. In the present study, circRNA_102231 was found to be one of the most significantly upregulated circRNAs in the GEO datasets analysis (GSE101586). QRT-PCR showed that circRNA_102231 expression was significantly upregulated in LAC tissues and associated with the advanced TNM stage, lymph node metastasis, and poor overall survival of lung cancer patients. The area under the receiver operating characteristic curve (ROC) was 0.897. in addition, function assays showed that circRNA_102231 inhibition significantly suppressed lung cancer cells proliferation and invasion ability in vitro. In conclusion, our study demonstrated that circRNA_102231 could act as a potential biomarker and therapeutic target for lung cancer patients.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Circular RNAs; Kaplan-Meier analysis; Lung cancer; Receiver operating characteristic; circRNA_102231

Mesh:

Substances:

Year:  2018        PMID: 29602132     DOI: 10.1016/j.biopha.2018.03.084

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  53 in total

1.  Construction of ceRNA network and identification of two differentially expressed circRNAs in hepatocellular carcinoma by bioinformatic analysis.

Authors:  Hongwei He; Zhong Shen; Qiyun Gu; Rong Xie
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

2.  CircPCNXL2 sponges miR-153 to promote the proliferation and invasion of renal cancer cells through upregulating ZEB2.

Authors:  Bisheng Zhou; Pengyi Zheng; Zhijun Li; Huibing Li; Xiaohui Wang; Zhenguo Shi; Qingjiang Han
Journal:  Cell Cycle       Date:  2018-12-10       Impact factor: 4.534

Review 3.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

Review 4.  Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer.

Authors:  Chunyan Li; Lin Zhang; Guangping Meng; Qi Wang; Xuejiao Lv; Jie Zhang; Junyao Li
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-19       Impact factor: 4.553

5.  Hsa_circ_0002577 promotes endometrial carcinoma progression via regulating miR-197/CTNND1 axis and activating Wnt/β-catenin pathway.

Authors:  Qiankun Shen; Tao He; Hongying Yuan
Journal:  Cell Cycle       Date:  2019-05-21       Impact factor: 4.534

6.  Exosomal circPVT1 derived from lung cancer promotes the progression of lung cancer by targeting miR-124-3p/EZH2 axis and regulating macrophage polarization.

Authors:  Ying Liu; Lei Li; Xiang Song
Journal:  Cell Cycle       Date:  2022-01-13       Impact factor: 4.534

7.  NRF1-regulated CircNSUN2 promotes lymphoma progression through activating Wnt signaling pathway via stabilizing HMGA1.

Authors:  Lifu Wang; Bo Yang; Ziguang Xu; Xiaoxia Song; Zhiquan Gong; Shuang Xue; Lingfei Kong
Journal:  Cell Cycle       Date:  2021-04-16       Impact factor: 4.534

Review 8.  Insights Into circRNAs: Functional Roles in Lung Cancer Management and the Potential Mechanisms.

Authors:  Bing Feng; Hao Zhou; Ting Wang; Xinrong Lin; Yongting Lai; Xiaoyuan Chu; Rui Wang
Journal:  Front Cell Dev Biol       Date:  2021-02-09

Review 9.  Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives.

Authors:  Huan-Huan Chen; Tie-Ning Zhang; Qi-Jun Wu; Xin-Mei Huang; Yu-Hong Zhao
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

10.  hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.

Authors:  Xuezuo Sui; Yanchun Wang; Hui Liu
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.